Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Akso Health GroupAHG +0.66%37 5-Year Yield-on-Cost % is 0.00 as of Jul. 15, 2026. GuruFocus rates AHG with a GF Score™ of 37/100 and a GF Value™ of $0.46 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 69 Medical Distribution companies, Akso Health Group ranks worse than 1449273.91% on this metric.
Akso Health Group's yield on cost for the quarter that ended in Sep. 2025 was 0.00.
The historical rank and industry rank for Akso Health Group's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 11 years, Akso Health Group's highest Yield on Cost was 75.29. The lowest was 7.42. And the median was 17.92.
AHG's 5-Year Yield-on-Cost % is not ranked *
in the Medical Distribution industry.
Industry Median: 3.76 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Akso Health Group (NAS:AHG) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Akso Health Group 5-Year Yield-on-Cost % Related Terms
AHG vs ACH, FOCL, YI: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Akso Health Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akso Health Group 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Akso Health Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Akso Health Group's 5-Year Yield-on-Cost % falls into.
Akso Health Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Akso Health Group (AHG) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Akso Health Group and its competitors. Over the past decade, Akso Health Group's 5-Year Yield-on-Cost % has ranged from 7.42 to 75.29. According to the industry distribution chart, Akso Health Group ranks #999999 out of 69 companies in the Medical Distribution industry.
Is Akso Health Group's 5-Year Yield-on-Cost % too high?
Akso Health Group's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 7.42 to a high of 75.29. Based on the distribution chart, Akso Health Group ranks #999999 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Akso Health Group has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Akso Health Group's 5-Year Yield-on-Cost % compare to ACH and FOCL?
According to the Medical Distribution industry distribution chart, Akso Health Group ranks #999999 out of 69 companies for 5-Year Yield-on-Cost %. This places Akso Health Group in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.76. Historically, Akso Health Group's own 5-Year Yield-on-Cost % has ranged from 7.42 to 75.29 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.76, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Akso Health Group and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akso Health Group's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akso Health Group stock overvalued right now?
Based on GuruFocus' analysis, Akso Health Group (AHG) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.46, compared to a current price of $1.53 — trading 232.6% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Akso Health Group's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Akso Health Group (AHG), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akso Health Group (AHG) Overvalued in 2026?
Based on GuruFocus' analysis, Akso Health Group stock appears to be overvalued.
The current stock price of $1.53 is trading 232.6% above its estimated GF Value™ of $0.46.
GuruFocus considers Akso Health Group to be Significantly Overvalued.
Key valuation signals for AHG:
5-Year Yield-on-Cost %: 0.00
GF Value™: $0.46 vs. price of $1.53 (232.6% above fair value)
No single metric tells the full story. See the AHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
37GF Score
Get the complete analysis for AHG
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHG has been successfully added to your 
